Eos Energy stock falls after Fuzzy Panda issues short report
Investing.com -- Emeis reported third-quarter revenues of €1,480 million, up 5.6% overall and 7.0% on a like-for-like basis, showing slight acceleration compared to the first half of 2025.
The healthcare provider saw its shares rise 6.7% following the announcement, as the company benefited from improved occupancy rates and higher prices across its operations.
Nursing Homes, representing 65% of sales, grew 8.4% like-for-like in the quarter, maintaining momentum from the first half’s 8.6% growth. This segment achieved an 88% occupancy rate in Q3, up 200 basis points, while benefiting from regulatory-related tariff increases.
The Clinics segment, accounting for 35% of sales, accelerated to 4.4% like-for-like growth in Q3, compared to 1.8% in the first half, driven by increased volumes and price effects.
By region, Northern Europe and Central Europe both posted strong 10.9% like-for-like growth in Q3. France, the company’s largest market at 41% of sales, saw 4.0% like-for-like growth, a significant improvement from the 1% growth in the first half. Southern Europe and Latin America delivered 9.7% like-for-like growth.
Emeis confirmed its 2025 objectives, including a 15-18% increase in EBITDAR at constant perimeter. The company has completed €2.1 billion in disposals since mid-2022, with €1.1 billion in secured disposals to date.
For the medium term, Emeis targets 4-5% compound annual revenue growth and 12-16% EBITDAR growth between 2024 and 2028, supported by continued occupancy rate improvements and operating expense control.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.